Compare GraniteShares 2x Long COIN Daily ETF (CONL) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GraniteShares 2x Long COIN Daily ETF vs Johnson & Johnson — how do they compare? GraniteShares 2x Long COIN Daily ETF trades at $5.3 (market cap $510.01M), while Johnson & Johnson trades at $261.41 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 1211.9× GraniteShares 2x Long COIN Daily ETF's market cap, and Johnson & Johnson pays a 2.09% dividend while GraniteShares 2x Long COIN Daily ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold GraniteShares 2x Long COIN Daily ETF for 15 Days and Johnson & Johnson for 129 Days on average.
| CONL | JNJ | |
|---|---|---|
Market Cap | $510.01M | $618.09B |
Volume | 21,041,836 | 6,050,983 |
Sector | Leveraged / Inverse | Health |
52-Week High | $48.58 | $278.43 |
52-Week Low | $3.93 | $186.00 |
Typical Hold Time | 15 Days | 129 Days |
Enterprise Value | — | $646.37B |
Dividend Yield | — | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CONL, a leveraged ETF tracking COIN, trades at $5.26, up 0.57% today. Technical indicators show mixed signals with a bearish overall trend but bullish oscillators including oversold RSI readings. The stock faces resistance at $5 and support at $4. Recent news highlights volatility with significant price gaps and volume spikes.
Outlook remains highly volatile given the leveraged structure and dependence on COIN performance. Investment opportunities exist for short-term traders capitalizing on momentum swings, but risks include amplified losses, regulatory uncertainty, and crypto market sensitivity. Long-term investors should approach with caution.
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GraniteShares 2x Long COIN Daily ETF
CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.
Read more on CONL →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
